Commentary · 31 Jan 2025
Conference abstractPublished 31 Aug 2020
Development of prohibitin ligands to treat cancers, cardiac and immunological disorders
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Over the last three decades, the scaffold proteins prohibitins-1 and -2 (PHB1/2) have emerged as key signaling proteins regulating a myriad of signaling pathways in health and diseases. Small molecules targeting PHBs display promising effects against several disease. With our collaborators we developed analogues of natural products belonging to the class of flavaglines that block the interaction between PHBs and C-RAF and, thereby, inhibit C-RAF-MEK-ERK signalling, which is critical to survival and proliferation of cancer cells. We also demonstrated that these compounds protect the heart from the adverse effects of cancer chemotherapies involving anthracyclines. We showed that this cardioprotection is mediated by the activation of the mitochondrial PHB-STAT3 complex. In addition to these lines of research, we also developed new PHB ligands belonging to the classes of spiro-oxindoles and triazines that respectively promote cardioprotection and modulate the biosynthesis of melanin in melanocytes. The structure-activity relationships of these new drugs and their detailed mechanism of action will also be presented.
Subjects
ChemistryPharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Chemical Biology & Pharmaceutical Chemistry.
Brief report · 31 Jan 2025
Chemical Biology Approaches to Modulate Protein–protein Interactions in Cancer Therapy
Opinion · 31 Jan 2025
Advances in Nanocarrier-based Drug Delivery: Bridging Chemistry and Pharmacology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Chemical Biology & Pharmaceutical Chemistry
- SubjectChemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Laurent Désaubry”
